Monotherapy with Lopinavir/Ritonavir as maintenance after HIV-1 viral suppression: results of a 96-week randomized, controlled, open-label, pilot trial (KalMo study). [electronic resource]
Producer: 20100331Description: 368-74 p. digitalISSN:- 1528-4336
- Adult
- Antiretroviral Therapy, Highly Active -- adverse effects
- CD4 Lymphocyte Count
- Drug Combinations
- Drug Resistance, Viral -- genetics
- Female
- HIV Infections -- drug therapy
- HIV Protease Inhibitors -- administration & dosage
- HIV-1 -- drug effects
- Humans
- Lopinavir
- Male
- Middle Aged
- Pilot Projects
- Pyrimidinones -- administration & dosage
- Ritonavir -- administration & dosage
- Semen -- virology
- Time Factors
- Treatment Outcome
- Viral Load -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.